Daily pill may replace growth hormone shots for children

NCT ID NCT07129759

Not yet recruiting Disease control Sponsor: Lumos Pharma Source: ClinicalTrials.gov ↗

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This study evaluates the long-term safety of an oral medication called LUM-201 for children with growth hormone deficiency (GHD). Children who completed a prior 12-month trial can receive LUM-201 daily for up to 36 additional months. The goal is to see if the pill is safe and tolerable over the long term, offering a potential alternative to daily injections.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: LUM-201 (an oral drug to stimulate growth)
What this could lead to: If successful, this could provide a daily pill alternative to daily injections for managing growth hormone deficiency in children.
What could go wrong: This is an extension study focused on safety, not on proving effectiveness. Long-term side effects or lack of sustained benefit remain possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GROWTH HORMONE DEFICIENCY (GHD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

isolated congenital growth hormone deficiency pituitary dwarfism

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GROWTH HORMONE DEFICIENCY (GHD)

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.